Benefits
Circulation: Not Tested in Modern Trials
The circulation claim for bilberry traces back to a 1972 controlled trial in varicose veins and to studies of capillary permeability in diabetic rats. No modern randomized trial has tested this extract, or any bilberry extract on its own at these doses, on human circulation. A 4-week randomized crossover trial giving 20 adults with type 2 diabetes 1.4 g a day of bilberry extract found no effect on blood pressure or blood lipids.
Focusing and Eye Strain After Screen Work
Randomized trials of bilberry extract in office workers report better pupil response, better flicker fusion and less eye strain after screen sessions: a capsule supplying 43.2 mg of bilberry anthocyanins daily for 6 weeks in 32 adults, 240 mg a day of a different Japanese bilberry extract for 12 weeks in 109 adults, and 480 mg a day of another bilberry extract for 8 weeks in 88 adults. All three were paid for by the company selling the extract tested, and in the smallest of them the significant result came from an analysis of individual eyes rather than of whole participants. No trial of bilberry has measured retinal blood flow or oxygen delivery in people.
Night Vision and Contrast Sensitivity: Controlled Trials Were Negative
A systematic review of placebo-controlled trials found that the four most recent randomized trials of bilberry anthocyanosides for night vision were all negative, and concluded that the hypothesis that bilberry improves normal night vision is not supported by evidence from rigorous clinical studies. In one of those trials, 15 young men with good vision took 160 mg of a 25% bilberry extract three times a day for 3 weeks in a crossover design, and there was no change in night visual acuity or night contrast sensitivity. The wartime story about RAF pilots and bilberry jam is not supported by any published trial. Bilberry has not been rigorously tested in people whose night vision is impaired by eye disease.
Dry Eye: Weak Evidence, and It Comes From Other Products
The dry eye evidence comes from other products. A 4-week randomized trial of Mirtoselect, a bilberry extract made by Indena rather than BGG, found tear volume on the Schirmer test improved from baseline in the 11 people taking it while the 10 on placebo did not change, and no direct comparison between the two groups was reported. A 3-month study in 24 adults with severe dry eye gave 600 mg of bilberry extract together with 240 mg of fish oil, used no placebo and no blinding, and reported effect sizes rather than significance tests. The one trial of BGG's own extract measured tear film break-up time and the Schirmer test as secondary outcomes and reported no improvement in either.
Antioxidant Activity in the Lab, Not Shown in People
Bilberry anthocyanins are antioxidants in laboratory assays. When this was tested in people, a randomized crossover trial giving 20 adults with type 2 diabetes 1.4 g a day of bilberry extract for 4 weeks found no change in antioxidant status, oxidative stress markers or inflammatory markers compared with placebo.
BGG Quality Standards
Adulteration is a real problem in this category. An analysis of 14 bilberry extracts and 12 finished bilberry supplements found that about half the extracts differed significantly from authentic bilberry, roughly 60% of extracts and 33% of finished supplements contained less anthocyanin than declared, and the main adulterants were mulberry and chokeberry. A separate analysis at a German university rated 45% of bilberry supplements unacceptable, including products that contained no bilberry at all. In a third case an extract that read 25% anthocyanins on the standard UV assay turned out to be carrying a synthetic red dye that only HPLC could detect. Buying an extract with a published HPLC anthocyanin specification and identity testing, which BGG publishes for MyrtiPRO, is a reasonable response to that. It is a statement about what is in the capsule, not about what the capsule does.
Mechanism of action
Anthocyanin Capillary Integrity
Anthocyanins reduced capillary permeability in diabetic rats. This has not been measured in people taking bilberry extract.
Retinal Microcirculation
Proposed but not demonstrated. No published trial has measured retinal or ocular blood flow in people taking bilberry extract on its own.
Antioxidant Activity
Bilberry fruit contains about 15 distinct anthocyanins, and that profile is what identity testing checks against. They behave as antioxidants in laboratory assays, but blood measures of antioxidant status did not change in a randomized trial of bilberry extract in people.
Authenticated Source
BGG publishes an HPLC anthocyanin specification and identity testing for MyrtiPRO. Reported bilberry adulterants are not limited to related species: they include mulberry and chokeberry extracts, other Vaccinium species, elderberry, and at least one case of a synthetic azo dye, amaranth, which passed the standard UV anthocyanin assay and was caught only by HPLC.
Clinical trials
Ozawa Y and colleagues, J Nutr Health Aging 2015;19(5):548-54. An 8-week randomized, double-blind, placebo-controlled trial of bilberry extract 480 mg/day in Japanese office workers using video display terminals. The work was conducted by Wakasa Seikatsu Co., Ltd., the company selling the extract, which employs two of the authors. The extract tested was not BGG's.
88 office workers aged 20 to 40 with relatively low critical flicker fusion and near point accommodation, screened from 281 candidates; 43 on bilberry extract and 37 on placebo completed.
The reduction in critical flicker fusion caused by screen work was smaller after 8 weeks on bilberry extract than on placebo (95% CI 0.10 to 1.60, p = 0.023). Near point accommodation did not differ between groups. Five of 18 subjective eye strain symptoms improved more than placebo. No severe adverse events occurred in either group.
Sekikawa T, Kizawa Y, Takeoka A, Sakiyama T, Li Y, Yamada T. Functional Foods in Health and Disease 2021;11(3):116-146. A 6-week randomized, double-blind, placebo-controlled parallel-group trial of a bilberry capsule supplying 43.2 mg of anthocyanins a day, roughly 120 mg of extract at BGG's stated standardization. Supported by BGG Japan Co., Ltd. and Arysta Health and Nutrition Sciences Corp. The paper does not name the product; BGG's own announcement identifies it as MyrtiPRO. The journal is not indexed in PubMed; the paper carries doi 10.31989/ffhd.v11i3.782.
32 healthy Japanese adults with eye fatigue after using video display terminals; 15 per group were included in the efficacy analysis.
In an additional analysis of individual eyes rather than of whole participants, the change in percentage pupillary response before and after screen work favoured the bilberry group (p = 0.043), and a pupillary response and near point measure also favoured it (p = 0.049). Tear film break-up time, Schirmer's test, muscle hardness and subjective symptoms were secondary outcomes and no improvement in them is reported. No adverse events were reported. This is one small trial funded by the ingredient's maker, and it measured no vascular outcome of any kind.